Preserving Muscle During Weight Loss: Review of Pharmacological Approaches | Research

The takeaway

A comprehensive review examines emerging pharmacological strategies to preserve lean body mass during GLP-1 RA and obesity medication-induced weight loss.

Significant lean mass loss
All obesity medications cause muscle loss alongside fat loss, driving research into preservation strategies

What the researchers found

Multiple pharmacological strategies are being investigated to preserve lean mass during obesity medication-induced weight loss, addressing a critical gap in current treatment.

Why it matters

Muscle loss during weight loss can undermine long-term health benefits. Finding effective lean mass preservation strategies is essential as millions use GLP-1 RAs.

How the study worked

Narrative review of emerging pharmacological approaches for lean body mass preservation during weight loss therapy.

What this study cannot tell us

Review of emerging approaches — most preservation strategies are in early development with limited clinical data.

How to read the evidence

Narrative review — provides a comprehensive overview of the field but most discussed strategies lack mature clinical evidence.

When this study was published

Published 2026 in Journal of Clinical Medicine.

The bigger picture

The "muscle loss problem" with GLP-1 RAs could become the next major focus in obesity medicine, driving development of combination therapies that maximize fat loss while protecting muscle.

Questions still open

Will muscle-preserving agents be combined with GLP-1 RAs in future treatment protocols?
Is resistance exercise sufficient, or is pharmacological muscle preservation necessary?

Common questions

Do GLP-1 drugs cause muscle loss?

Yes — like all methods of significant weight loss, GLP-1 medications cause some loss of lean body mass (muscle) alongside fat loss. This is an active area of research.

How can you prevent muscle loss while on weight loss drugs?

Currently, resistance exercise is the best strategy. Researchers are also investigating drugs like myostatin inhibitors that could be combined with obesity medications to preserve muscle.

Read the original research

Pharmacologic Treatments for the Preservation of Lean Body Mass During Weight Loss.

Journal of clinical medicine, 15(2)

View on PubMed ↗Publisher’s paper ↗

Citation

Arora, Gunjan; Conde, Katherine R; Desouza, Cyrus V. (2026). Pharmacologic Treatments for the Preservation of Lean Body Mass During Weight Loss.. Journal of clinical medicine, 15(2). https://doi.org/10.3390/jcm15020541